176 Bull. Chem. Soc. Jpn., 77, No. 1 (2004)
6-Nitro-2-benzothiazolyl Glycoside
O-benzyl-D-glucopyranosyl)-2-phthalimido-1-thio-ꢁ-D-gluco-
pyranoside (15): The ratios were determined by HPLC analy-
sis11c (hexane/ethyl acetate = 4/1; flow rate, 1.0 mL/min; 20.8
min, ꢀ-isomer; 23.7 min, ꢁ-isomer).
pyranoside (21): This compound was synthesized from mannosyl
donor 18ꢀ and glycosyl acceptor 11.11c
21ꢀ: colorless oil; Rf 0.41 (hexane/ethyl acetate, 2/1, v/v);
21
½ꢁꢅD þ30:2ꢂ (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) ꢂ
6-Nitro-2-benzothiazolyl 2,3,4,6-Tetra-O-benzyl-D-manno-
pyranoside (18). To a solution of 2,3,4,6-tetra-O-benzyl-D-man-
nopyranose28 17 (50.0 mg, 92.5 mmol) in THF (1.0 mL) was added
potassium bis(trimethylsilyl)amide (0.50 M in toluene, 0.22 mL,
0.11 mmol) at 0 ꢂC. After stirring for 0.5 h at the same temperature,
2 (23.8 mg, 0.11 mmol) was added to the reaction mixture. Then
the reaction mixture was stirring for 0.5 h at room temperature.
The reaction was quenched by adding sat. aq. NaHCO3. The aque-
ous layer was extracted with EtOAc, and the combined organic lay-
er was washed with brine and dried over Na2SO4. After filtration
and evaporation, the residue was purified by preparative TLC (sili-
ca gel) to afford 18ꢀ (44.0 mg, 66%) and 18ꢁ (16.1 mg, 24%).
18ꢀ: colorless oil; Rf 0.54 (hexane/ethyl acetate, 7/3, v/v);
1.14 (3H, t, J ¼ 7:0 Hz), 1.79 (3H, s), 2.57–2.65 (2H, m), 3.59
(1H, t, J ¼ 9:5 Hz), 3.63–3.68 (2H, m), 3.73–3.80 (3H, m), 3.84
(1H, s), 3.89–3.92 (2H, m), 4.02 (1H, t, J ¼ 9:5 Hz), 4.24 (1H, t,
J ¼ 9:5 Hz), 4.50 (1H, d, J ¼ 12:5 Hz), 4.53 (1H, d, J ¼ 11:0
Hz), 4.54 (2H, s), 4.66 (1H, d, J ¼ 12:5 Hz), 4.67 (2H, s), 4.76
(2H, s), 4.92 (1H, d, J ¼ 11:0 Hz), 5.07 (1H, s, H-10), 5.48 (1H,
d, J ¼ 9:5 Hz, H-1), 5.81 (1H, t, J ¼ 9:5 Hz), 7.19–7.37 (23H,
m, Ar-H), 7.43 (2H, d, J ¼ 7:0 Hz, Ar-H), 7.71–7.74 (2H, m,
Ar-H), 7.83–7.88 (2H, m, Ar-H); 13C NMR (125 MHz, CDCl3) ꢂ
14.90, 20.43, 24.33, 54.31, 65.63, 69.17, 71.92, 71.95, 72.35,
73.16, 74.06, 74.54, 74.85, 74.89, 76.53, 78.50, 79.36, 80.77 (C-
1), 98.31 (C-10, JC{H ¼ 170 Hz), (123.40, 123.52, 131.20,
131.72, 134.04, 134.20, 167.40, 167.59) (C-Phth), (127.27–
128.31, 137.68, 138.26, 138.39, 138.41, 138.47) (C-Ar), 169.85;
IR (neat) 702, 748, 1103, 1381, 1712, 2353, 3016 cmꢁ1; HRMS
23
½ꢁꢅD þ63:2ꢂ (c 1.00, CHCl3); 1H NMR (270 MHz, CDCl3) ꢂ
3.74 (1H, dd, J ¼ 1:6, 10.8 Hz), 3.82 (1H, dd, J ¼ 4:6, 10.8 Hz),
3.95–4.02 (2H, m), 4.08 (1H, t, J ¼ 1:9 Hz), 4.17 (1H, t, J ¼ 9:5
Hz), 4.52 (1H, d, J ¼ 11:9 Hz), 4.55 (1H, d, J ¼ 10:5 Hz), 4.60
(1H, d, J ¼ 11:3 Hz), 4.65 (1H, d, J ¼ 11:9 Hz), 4.66 (1H, d, J ¼
11:3 Hz), 4.83 (2H, s), 4.91 (1H, d, J ¼ 10:5 Hz), 6.48 (1H, d, J ¼
1:9 Hz, H-1), 7.16–7.46 (20H, m, Ar-H), 7.74 (1H, d, J ¼ 8:9 Hz),
8.25 (1H, dd, J ¼ 2:2, 8.9 Hz), 8.55 (1H, d, J ¼ 2:2 Hz); 13C NMR
(67.8 MHz, CDCl3) ꢂ 68.52, 72.34, 72.76, 72.97, 73.28, 73.86,
74.69, 75.16, 78.86, 98.68 (C-1, JC{H ¼ 178 Hz), (127.48–
128.35, 137.54, 137.86, 137.93, 137.96) (C-Ar), (117.76, 121.18,
121.87, 132.25, 143.84, 153.50, 173.74) (Benzothiazole); IR (neat)
748, 895, 1119, 1342, 1520, 2916 cmꢁ1; HRMS m=z calcd for
C41H38N2O8 NH4 [M + NH4]þ 736.2693, found 736.2682.
m=z calcd for C59H61NO12S NH4 [M + NH4]þ 1025.4258, found
ꢃ
1025.4266.
21ꢁ: colorless amorphous material; Rf 0.34 (hexane/ethyl ace-
22
tate, 2/1, v/v); ½ꢁꢅD ꢁ15:8ꢂ (c 1.00, CHCl3); 1H NMR (500
MHz, CDCl3) ꢂ 1.13 (3H, t, J ¼ 7:0 Hz), 1.81 (3H, s), 2.52–2.65
(2H, m), 3.43–3.46 (1H, m), 3.48 (1H, dd, J ¼ 2:5, 9.0 Hz),
3.59–3.65 (2H, m), 3.76–3.82 (3H, m), 3.87 (1H, d, J ¼ 2:5 Hz),
3.93 (1H, t, J ¼ 9:0 Hz), 4.28–4.32 (2H, m), 4.34 (1H, s, H-10),
4.51–4.68 (7H, m), 4.90 (1H, d, J ¼ 12:0 Hz), 4.91 (1H, d, J ¼
11:0 Hz), 4.99 (1H, d, J ¼ 11:0 Hz), 5.48 (1H, d, J ¼ 10:5 Hz,
H-1), 5.85 (1H, t, J ¼ 9:5 Hz), 7.19–7.37 (23H, m, Ar-H), 7.50
(2H, d, J ¼ 7:0 Hz, Ar-H), 7.72–7.73 (2H, m, Ar-H), 7.85–7.88
(2H, m, Ar-H); 13C NMR (125 MHz, CDCl3) ꢂ 14.86, 20.40,
24.02, 54.27, 68.86, 69.52, 71.51, 73.39, 73.69, 73.75, 74.07,
74.29, 74.87, 75.00, 75.96, 77.15, 78.86, 80.63 (C-1), 82.18,
102.05 (C-10, JC{H ¼ 156 Hz), (123.39, 123.46, 131.21, 131.74,
133.92, 134.18, 167.40, 167.59) (C-Phth), (127.30–128.32,
137.61, 138.12, 138.31, 138.42, 138.68) (C-Ar), 169.80; IR (neat)
748, 1103, 1227, 1381, 1713, 2931 cmꢁ1; HRMS m=z calcd for
ꢃ
18ꢁ: colorlꢂess solid; Rf 0.42 (hexane/ethyl acetate, 7/3, v/v);
Mp 109–110 C; ½ꢁꢅD ꢁ25:6ꢂ (c 1.00, CHCl3); H NMR (270
MHz, CDCl3) ꢂ 3.72–3.86 (4H, m), 4.05 (1H, t, J ¼ 8:6 Hz),
4.24 (1H, d, J ¼ 1:6 Hz), 4.51 (1H, d, J ¼ 12:2 Hz), 4.57 (1H,
d, J ¼ 10:8 Hz), 4.61 (1H, d, J ¼ 12:2 Hz), 4.64 (1H, d, J ¼
11:6 Hz), 4.70 (1H, d, J ¼ 11:6 Hz), 4.88 (1H, d, J ¼ 10:8 Hz),
4.88 (2H, s), 6.00 (1H, brs, H-1), 7.16–7.72 (20H, m, Ar-H),
7.70 (1H, d, J ¼ 9:2 Hz), 8.25 (1H, dd, J ¼ 2:2, 9.2 Hz), 8.56
(1H, d, J ¼ 2:2 Hz); 13C NMR (67.8 MHz, CDCl3) ꢂ 68.89,
72.31, 72.86, 73.37, 74.04, 74.12, 74.84, 76.46, 81.06, 99.52 (C-
1, JC{H ¼ 162 Hz), (127.53–128.44, 137.77, 137.80, 137.91,
137.96) (C-Ar), (117.79, 121.15, 121.83, 132.41, 143.89, 153.39,
174.30) (Benzothiazole); IR (KBr) 702, 748, 1103, 1342, 1520,
23
1
C59H61NO12S NH4 [M + NH4]þ 1025.4258, found 1025.4260.
ꢃ
2,3,4-Tri-O-benzyl-6-O-(20,30,40,60-tetra-O-benzyl-D-manno-
pyranosyl)-ꢁ-D-glucopyranosyl Fluoride (22): This compound
was synthesized from mannosyl donor 18ꢀ and glycosyl acceptor
12.5d
22ꢀ: colorless oil; Rf 0.50 (hexane/ethyl acetate, 2/1, v/v);
21
2916 cmꢁ1; HRMS m=z calcd for C41H38N2O8 NH4 [M + NH4]þ
736.2693, found 736.2704.
½ꢁꢅD þ36:4ꢂ (c 1.12, CHCl3); 1H NMR (500 MHz, CDCl3) ꢂ
ꢃ
3.53–3.60 (3H, m), 3.63–3.76 (5H, m), 3.84 (1H, s), 3.87–3.90
(2H, m), 4.01 (1H, t, J ¼ 9:0 Hz), 4.47–4.53 (3H, m), 4.60–4.65
(3H, m), 4.71–4.81 (5H, m), 4.85–4.91 (3H, m), 5.03 (1H, s, H-
10), 5.26 (1H, dd, J ¼ 6:0, 53.0 Hz, H-1), 7.16–7.42 (35H, m,
Ar-H); 13C NMR (125 MHz, CDCl3) ꢂ 65.67, 69.18, 71.85,
72.10, 72.35, 73.19, 74.09 (d, J ¼ 1:9 Hz), 74.38 (d, J ¼ 3:6
Hz), 74.50, 74.77, 74.82, 74.87, 75.16, 76.52, 79.35, 81.24 (d, J ¼
22:9 Hz), 83.38 (d, J ¼ 10:1 Hz), 98.61 (C-10, JC{H ¼ 170 Hz),
109.48 (d, J ¼ 216 Hz, C-1), (127.25–128.37, 137.58, 138.10,
138.33, 138.42, 138.60) (C-Ar); IR (neat) 694, 741, 1095, 1458,
1496, 1604, 1737, 1959, 2931 cmꢁ1; HRMS m=z calcd for
Mannosylation Using H[B(C6F5)4] as Catalyst (The General
Procedure). To a stirred suspension of MS 5A (150 mg), manno-
syl donor (0.06 mmol) and glycosyl acceptor (0.050 mmol) in
CH2Cl2 (1.25 mL) was successively added H[B(C6F5)4] (0.050
M toluene–Et2O (1:1), 0.20 mL, 0.01 mmol) at ꢁ78 ꢂC. After
the completion of the mannosylation reaction was verified by mon-
itoring TLC, the reaction was quenched by addition of sat. aq.
NaHCO3. Then, the mixture was filtered through Celite and the
aqueous layer was extracted with CH2Cl2. The combined organic
layer was washed with brine and dried over Na2SO4. After filtra-
tion and evaporation, the resulting residue was purified by prepara-
tive TLC (silica gel) and afforded the corresponding disaccharide.
The ꢁ to ꢀ ratios for 19,11a 21, 22, 23, and 24 were determined by
isolations of both isomers.
C61H63O10F NH4 [M + NH4]þ 992.4749, found 992.4764.
ꢃ
22ꢁ: colorless solid; Rf 0.43 (hexane/ethyl acetate, 2/1, v/v);
22
Mp 129–130 ꢂC; ½ꢁꢅD ꢁ5:0ꢂ (c 0.85, CHCl3); 1H NMR (500
MHz, CDCl3) ꢂ 3.43–3.46 (2H, m), 3.53–3.62 (3H, m), 3.70–
3.82 (4H, m), 3.87 (1H, d, J ¼ 3:0 Hz), 3.91 (1H, t, J ¼ 9:5 Hz),
4.26 (1H, d, J ¼ 10:5 Hz), 4.29 (1H, s, H-10), 4.50–4.66 (7H,
Ethyl 3-O-Acetyl-4-O-benzyl-2-deoxy-6-O-(20,30,40,60-tetra-
O-benzyl-D-mannopyranosyl)-2-phthalimido-1-thio-ꢁ-D-gluco-